Skip to content
PICO Portalanswers from OpenAlex

Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients

PaperCitations, authors & open-access status

Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients is a paper indexed in PICO Portal from OpenAlex.

How many citations does Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients have?

PICO Portalcitation count

Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients has 226 citations in the OpenAlex counts PICO Portal stores.

When was Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients published?

PICO Portalyear

Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients has 2003 year in the PICO Portal index.

What is the open-access status of Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients?

PICO Portaloa status

Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients has bronze oa status in the PICO Portal index.

What is the DOI of Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients?

PICO Portaldoi

The DOI for Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients is on the source record.

What is the PMID of Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients?

PICO Portalpmid

The PMID for Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients is on the source record.

What is the OpenAlex record for Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients?

PICO Portalopenalex

The OpenAlex for Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial